This page is part of the Quality Improvement Core Framework (v6.0.0-ballot: STU6 (v6.0.0) Ballot 1) based on FHIR R4. The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

• Content
• Detailed Descriptions
• Mappings
• XML
• JSON
• TTL

Resource Profile: QICoreMedication - Mappings

Active as of 2018-08-22

Mappings for the qicore-medication resource profile.

Mappings for Mapping to Quality Improvement Domain Analysis Model (http://hl7.org/qidam)

QICoreMedication
Medication
ingredient
isActive	Not in QIDAM, but added because it was determined to be important for drug-allergy checking. For example, if the patient is allergic to Depakote (a trade name, and includes blue dye as an inactive ingredient), then when patient is prescribed warfarin, it shoots out a drug-allergy alert because warfarin also contains blue dye. Providers hate this. We recently overcame this problem by having the drug-allergy alert interaction settings only check for allergies to active ingredients.

Mappings for Mapping to NCPDP SCRIPT 10.6 (http://ncpdp.org/SCRIPT10_6)

QICoreMedication
Medication	NewRx/MedicationPrescribed -or- RxFill/MedicationDispensed -or- RxHistoryResponse/MedicationDispensed -or- RxHistoryResponse/MedicationPrescribed
code	coding.code = //element(*,MedicationType)/DrugCoded/ProductCode coding.system = //element(*,MedicationType)/DrugCoded/ProductCodeQualifier coding.display = //element(*,MedicationType)/DrugDescription
manufacturer	no mapping
form	coding.code = //element(*,DrugCodedType)/FormCode coding.system = //element(*,DrugCodedType)/FormSourceCode
ingredient
item[x]	coding.code = //element(*,MedicationType)/DrugCoded/ProductCode coding.system = //element(*,MedicationType)/DrugCoded/ProductCodeQualifier coding.display = //element(*,MedicationType)/DrugDescription
strength	//element(*,DrugCodedType)/Strength
batch	no mapping
lotNumber	no mapping
expirationDate	no mapping

Mappings for RIM Mapping (http://hl7.org/v3)

QICoreMedication
Medication	Entity. Role, or Act, ManufacturedProduct[classCode=ADMM]
text	Act.text?
contained	N/A
extension	N/A
modifierExtension	N/A
identifier	.id
code	.code
status	.statusCode
manufacturer	.player.scopingRole[typeCode=MANU].scoper
form	.formCode
amount	.quantity
ingredient	.scopesRole[typeCode=INGR]
id	n/a
extension	n/a
modifierExtension	N/A
item[x]	.player
isActive	NA
strength	.quantity
batch	.player[classCode=CONT]
id	n/a
extension	n/a
modifierExtension	N/A
lotNumber	.id
expirationDate	participation[typeCode=CSM].role[classCode=INST].scopedRole.scoper[classCode=MMAT].expirationTime

Mappings for FiveWs Pattern Mapping (http://hl7.org/fhir/fivews)

QICoreMedication
Medication
identifier	FiveWs.identifier
code	FiveWs.class
manufacturer	FiveWs.actor

Mappings for HL7 v2 Mapping (http://hl7.org/v2)

QICoreMedication
Medication
code	RXO-1.1-Requested Give Code.code / RXE-2.1-Give Code.code / RXD-2.1-Dispense/Give Code.code / RXG-4.1-Give Code.code /RXA-5.1-Administered Code.code / RXC-2.1 Component Code
manufacturer	RXD-20-Substance Manufacturer Name / RXG-21-Substance Manufacturer Name / RXA-17-Substance Manufacturer Name
form	RXO-5-Requested Dosage Form / RXE-6-Give Dosage Form / RXD-6-Actual Dosage Form / RXG-8-Give Dosage Form / RXA-8-Administered Dosage Form
ingredient
item[x]	RXC-2-Component Code if medication: RXO-1-Requested Give Code / RXE-2-Give Code / RXD-2-Dispense/Give Code / RXG-4-Give Code / RXA-5-Administered Code
strength	RXC-3-Component Amount & RXC-4-Component Units if medication: RXO-2-Requested Give Amount - Minimum & RXO-4-Requested Give Units / RXO-3-Requested Give Amount - Maximum & RXO-4-Requested Give Units / RXO-11-Requested Dispense Amount & RXO-12-Requested Dispense Units / RXE-3-Give Amount - Minimum & RXE-5-Give Units / RXE-4-Give Amount - Maximum & RXE-5-Give Units / RXE-10-Dispense Amount & RXE-10-Dispense Units
batch
lotNumber	RXA-15 Substance Lot Number / RXG-19 Substance Lot Number
expirationDate	RXA-16 Substance Expiration Date / RXG-20 Substance Expiration Date